Michael S. Hearne's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 116,144 Common Stock done . Disclosure was reported to the exchange on May 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharma Inc | Michael S. Hearne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 116,144 | 116,144 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Michael S. Hearne | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 70,230 | 70,230 | - | - | Employee Stock Option (right to buy) |